Texas HB3318 allows patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments.

HB3318 establishes a framework for patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. Patients must have exhausted all FDA-approved treatments and provide informed consent. Health care facilities and manufacturers can offer these treatments without compensation. The bill prohibits state interference with patient access and shields patients' heirs from debt liability upon the patient's death. It also protects health care providers from disciplinary actions based solely on their recommendation of such treatments.

Texas HB3318 allows patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments.

HB3318 establishes a framework for patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. Patients must have exhausted all FDA-approved treatments and provide informed consent. Health care facilities and manufacturers can offer these treatments without compensation. The bill prohibits state interference with patient access and shields patients' heirs from debt liability upon the patient's death. It also protects health care providers from disciplinary actions based solely on their recommendation of such treatments.